Retina

Latest News


CME Content


Advanced Retinal Therapy will be held in Vienna, Austria on 3 December 2011. At this event updates, trends and controversies in retinal tehrapy will be discussed in symposia, key-note lectures and a panel discussion session.

OTEurope speaks with Dr Wolfgang Schalch about 'Critical parameters for lutein delivery systems' and the Actilease system.

This new technology will enable surgeons to perform treatments more accurately and comfortably in a short period of time.

Diagnostic and prognostic capabilities at the early stages of retinal diseases could be improved as a result of adaptive optics.

Dr Sebasiten Wolf describes how SD-OCT has improved the visualization of intraretinal morphologic feaures both quantatively and qualatively.

A novel nanosecond laser therapy has stopped the progression of age-related macular degeneration (AMD) and resulted in resolution of drusen and improved visual function in patients with early-stage high-risk AMD.

A specific diode laser is the latest technology to perform several different laser procedures in the ophthalmic practice. Its multi-use capabilities for glaucoma and retinal disease make it a strong choice for the office setting.

Combined genomic and proteomic biomarkers are seemingly the most effective method for predicting progression.

A report on the status of the 5-year-old ongoing MacTel Project, which is slowly answering questions surrounding the disease.

The efficacy and safety of two doses of a fluocinolone acetonide intravitreal insert for the treatment of DME were investigated in two sham-controlled phase III studies

Results from preclinical testing including a formal Good Laboratory Practice toxicity study, support the safety of a gene transfer agent, AAV2-sFLT01, when administered intravitreally. A phase I safety and tolerability study of this agent is currently underway.